Share

CDDF Multi Stakeholder Workshop on Patient Access & Engagement in Oncology Drug Development

Amsterdam, NL (Hybrid Event)

Patient and Public Involvement and Engagement (PPIE) is becoming a critically important component of all aspects of cancer research and its translation into better care, but there is currently a dearth of opportunities for the cancer community to learn about the latest developments and exemplars of best practice. The Cancer Drug Development Forum will organize a hybrid Multi-Stakeholder Workshop on 19-20 September 2022 in Amsterdam (NL). This event will provide an opportunity to discuss and debate how patient access and involvement in oncology drug development can be enhanced to ensure a truly patient-centred approach to delivering innovative medicines. The CDDF will bring together experts in the field in a series of 5 sessions over two half days, delivered through a series of keynote lectures, round tables, and discussion fora. Register today to save your seat and check the CDDF website for further information about the workshop.

Next events

  • EORTC Brain Tumour Group Autumn Meeting

    Vienna, AT

  • CDDF Multi Stakeholder Workshop on Patient Access & Engagement in Oncology Drug Development

    Amsterdam, NL (Hybrid Event)

  • EORTC Quality of Life Group Autumn Meeting

    Amsterdam, NL

  • Cutaneous Lymphoma Tumours Group Annual Meeting

    Madrid, Spain

  • EORTC Gynecological Cancer Group Autumn Meeting

    EORTC HQ, Brussels, Belgium